TOKIWA-Bio is developing Stealth RNA Vector (SRV), as a gene therapy vector, which does not integrate into the host chromosome, and can efficiently introduce multiple genes or large genes into cells effectively.
TOKIWA-Bio is committed to use SRV touching people that are suffering genetic diseases in the world. Currently, SRV is being studied in regenerative medicine as an excellent technology for reprogramming various cells. As SRV is safe with highest quality, it is the best technology for the industrialization of regenerative medicine.
Further more, high gene-expressing cells can be obtained within a short time, and applications for biopharmaceutical production is also anticipated. TOKIWA-Bio is expanding SRV technology around the world in aforementioned areas.